Skip to main content

Impact of imaging frequency on progression-free survival in Alliance trials enrolling patients with follicular lymphoma.

Publication ,  Journal Article
Rutherford, SC; Yin, J; Pederson, LD; Blum, KA; Martin, P; Jung, S-H; Grant, B; Rosenbaum, C; Cheson, BD; Bartlett, NL; Mandrekar, SJ; Leonard, JP
Published in: Blood Adv
March 26, 2024

Duke Scholars

Published In

Blood Adv

DOI

EISSN

2473-9537

Publication Date

March 26, 2024

Volume

8

Issue

6

Start / End Page

1464 / 1468

Location

United States

Related Subject Headings

  • Rituximab
  • Progression-Free Survival
  • Lymphoma, Follicular
  • Humans
  • Diagnostic Imaging
  • Antibodies, Monoclonal, Murine-Derived
  • 3201 Cardiovascular medicine and haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Rutherford, S. C., Yin, J., Pederson, L. D., Blum, K. A., Martin, P., Jung, S.-H., … Leonard, J. P. (2024). Impact of imaging frequency on progression-free survival in Alliance trials enrolling patients with follicular lymphoma. Blood Adv, 8(6), 1464–1468. https://doi.org/10.1182/bloodadvances.2023012090
Rutherford, Sarah C., Jun Yin, Levi D. Pederson, Kristie A. Blum, Peter Martin, Sin-Ho Jung, Barbara Grant, et al. “Impact of imaging frequency on progression-free survival in Alliance trials enrolling patients with follicular lymphoma.Blood Adv 8, no. 6 (March 26, 2024): 1464–68. https://doi.org/10.1182/bloodadvances.2023012090.
Rutherford SC, Yin J, Pederson LD, Blum KA, Martin P, Jung S-H, et al. Impact of imaging frequency on progression-free survival in Alliance trials enrolling patients with follicular lymphoma. Blood Adv. 2024 Mar 26;8(6):1464–8.
Rutherford, Sarah C., et al. “Impact of imaging frequency on progression-free survival in Alliance trials enrolling patients with follicular lymphoma.Blood Adv, vol. 8, no. 6, Mar. 2024, pp. 1464–68. Pubmed, doi:10.1182/bloodadvances.2023012090.
Rutherford SC, Yin J, Pederson LD, Blum KA, Martin P, Jung S-H, Grant B, Rosenbaum C, Cheson BD, Bartlett NL, Mandrekar SJ, Leonard JP. Impact of imaging frequency on progression-free survival in Alliance trials enrolling patients with follicular lymphoma. Blood Adv. 2024 Mar 26;8(6):1464–1468.

Published In

Blood Adv

DOI

EISSN

2473-9537

Publication Date

March 26, 2024

Volume

8

Issue

6

Start / End Page

1464 / 1468

Location

United States

Related Subject Headings

  • Rituximab
  • Progression-Free Survival
  • Lymphoma, Follicular
  • Humans
  • Diagnostic Imaging
  • Antibodies, Monoclonal, Murine-Derived
  • 3201 Cardiovascular medicine and haematology